Boston Scientific Corporation ($BSX) Stock Forecast: Down 1.5% Today

What is Boston Scientific Corporation?

Boston Scientific (BSX) is a leading medical technology company that develops and manufactures medical devices used in interventional medical specialties. The broader market experienced a mixed trading day with some sectors showing slight gains.

Why is Boston Scientific Corporation going down?

BSX stock is down 1.5% on Dec 9, 2024 15:27

• The bearish movement in BSX could be attributed to insider selling activity by Emily Woodworth, a senior executive at the company, potentially raising concerns among investors about the company's future prospects.
• The overall market sentiment might have also played a role in the stock's decline, as investors may have been cautious due to uncertainties in the broader market.
• Despite the dip, BSX's long-term growth prospects and innovative product pipeline could still make it an attractive investment opportunity for those looking to capitalize on the healthcare sector's potential.

BSX Price Chart

BSX Technical Analysis

BSX News

Boston Scientific ( BSX ) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Boston Scientific (BSX) closed at $90.53 in the latest trading session, marking a -0.34% move from the prior day.

https://www.zacks.com/stock/news/2379876/boston-scientific-bsx-sees-a-more-significant-dip-than-broader-market-some-facts-to-know

Insider Decision: Emily Woodworth Offloads $121K Worth Of Boston Scientific Stock - Boston Scientific ( NYSE:BSX )

On December 2, a recent SEC filing unveiled that Emily Woodworth, SVP at Boston Scientific BSX made an insider sell. What Happened: Woodworth's decision to sell 1,336 shares of Boston Scientific was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday.

https://www.benzinga.com/insights/news/24/12/42293211/insider-decision-emily-woodworth-offloads-121k-worth-of-boston-scientific-stock

Trending Today

Aave ($AAVE) Crypto Forecast: Up 14.0% Today

Horizen ($ZEN) Crypto Forecast: Up 24.3% Today

ZCash ($ZEC) Crypto Forecast: Up 9.1% Today

The Graph ($GRT) Crypto Forecast: Up 6.9% Today

Hedera Hashgraph ($HBAR) Crypto Forecast: Up 10.7% Today

Solana ($SOL) Crypto Forecast: Up 5.1% Today

Ethereum ($ETH) Crypto Forecast: Up 5.3% Today

Arbitrum ($ARB) Crypto Forecast: Up 8.0% Today

Cardano ($ADA) Crypto Forecast: Up 5.2% Today

Shiba Inu ($SHIB) Crypto Forecast: Up 5.0% Today

Boston Scientific Corporation Price History

23.09.2024 - BSX Stock was down 5.0%

• Despite exceeding Q3 earnings and revenue estimates, BSX faced a significant bearish movement in the market today.
• Investor sentiment in the options market may have contributed to the downward pressure on BSX stock.
• A downgrade by a top Wall Street analyst could have influenced the bearish movement.
• The recent FDA approval for the FARAWAVE NAV Ablation Catheter and FARAVIEW Software, which was anticipated to drive up BSX shares, did not lead to a notable impact on the market today.

24.09.2024 - BSX Stock was up 2.3%

• Boston Scientific Corporation paused enrollment in the Farapulse study for drug-naive patients with irregular heart rhythm, a move that could enhance product safety and efficacy, potentially boosting investor confidence.
• Despite a slight premarket stock decline linked to a decrease in operating margin, BSX posted promising Q3 earnings surpassing revenue and EPS expectations, resulting in an improved annual forecast. This financial success likely contributed to the bullish market activity.
• Investors' optimistic outlook on Boston Scientific, demonstrated through options trading patterns, signifies a high level of confidence in the company's future growth prospects, further fueling the stock's uptrend.
• The strong performance in legacy businesses and robust demand for heart devices shown in the Q3 earnings report may have also been key factors in driving BSX towards a bullish market movement today.

09.11.2024 - BSX Stock was down 1.5%

• The bearish movement in BSX could be attributed to insider selling activity by Emily Woodworth, a senior executive at the company, potentially raising concerns among investors about the company's future prospects.
• The overall market sentiment might have also played a role in the stock's decline, as investors may have been cautious due to uncertainties in the broader market.
• Despite the dip, BSX's long-term growth prospects and innovative product pipeline could still make it an attractive investment opportunity for those looking to capitalize on the healthcare sector's potential.

13.10.2023 - BSX Stock was up 2.8%

• Short interest in BSX has fallen, indicating a decrease in bearish sentiment towards the stock.
• Positive investor sentiment is driven by growing demand for WATCHMAN FLX devices and upbeat guidance.
• Decreased stock position by Diamond Hill Capital Management suggests a potential reduction in selling pressure.
• The company's focus on AI innovations in the medtech industry, as highlighted by Sandra Nagale, may have contributed to positive market sentiment.

27.10.2023 - BSX Stock was down 1.0%

• The bearish movement in BSX's stock today could be attributed to several factors:
• 1. Profit-taking: After a significant increase in the stock price over the past month and year, some investors may have decided to sell their shares and take profits, leading to a downward pressure on the stock.
• 2. Market sentiment: The overall market sentiment towards healthcare stocks may have turned negative, causing investors to sell off their positions in BSX and other healthcare companies.
• 3. Lack of positive news: While there have been recent acquisitions and advancements mentioned in the news articles, there may not have been any specific positive news or developments directly impacting BSX today, leading to a lack of catalysts to drive the stock price higher.
• 4. Technical factors: The stock's price movement could also be influenced by technical factors, such as resistance levels or trading patterns, which may have triggered selling pressure.
• Overall, the bearish movement in BSX's stock today could be a result of profit-taking, negative market sentiment, lack of positive news, and technical factors.

11.09.2023 - BSX Stock was down 5.1%

• The bearish movement in BSX today can be attributed to the following factors:
• 1. Profit-taking: After a period of consistent growth, investors may have decided to take profits, leading to a sell-off in the stock.
• 2. Market correction: The overall market may have experienced a downward trend, causing a negative impact on BSX and other stocks.
• 3. Technical factors: The technical benchmark of Integer Holdings, a competitor in the medical device industry, hitting an 80-plus RS rating may have drawn some investors' attention away from BSX, resulting in a decline in its stock price.
• Please note that the provided articles do not directly mention the bearish movement of BSX today.

24.03.2024 - BSX Stock was up 5.8%

• Boston Scientific (BSX) had a strong bullish movement today.
• This upward trend is linked to the company surpassing expectations in its first-quarter earnings report and providing optimistic guidance.
• First-quarter revenues of $3.86 billion exceeded the consensus estimate of $3.69 billion, demonstrating robust performance in core business areas.
• Shareholders responded positively to the positive earnings report, propelling the stock to achieve a 52-week high as they view Boston Scientific as a promising investment opportunity within the medical products industry.

24.03.2024 - BSX Stock was up 8.4%

• Boston Scientific (BSX) reported Q1 earnings and revenues that surpassed estimates, indicating strong financial performance and market confidence in the company's growth prospects.
• The positive earnings report and exceeding sales expectations propelled Boston Scientific's stock into buy zones, attracting investors and driving the bullish movement.
• The overall bullish market sentiment, with US broader indices up over 1% and stocks rising for the second consecutive day, also contributed to the upward momentum of BSX.
• Additionally, Boston Scientific received an IBD stock rating upgrade, further boosting investor confidence and interest in the company's stock.

11.02.2024 - BSX Stock was down 1.5%

• The stock of Boston Scientific (BSX) experienced a bearish movement despite being upgraded to a "buy" rating.
• The allegations against a former employee involved in a disturbing case of child abuse may have negatively impacted investor sentiment and contributed to the stock's decline.
• Despite the negative news surrounding the company, Boston Scientific has shown strong long-term performance, with a $1000 investment 10 years ago yielding significant returns.
• The market may have reacted to the news about Align Technology's improving technical performance, leading investors to shift focus away from Boston Scientific temporarily.

07.05.2024 - BSX Stock was up 1.9%

• Boston Scientific's stock showed a strong upward trend today, closing at $76.12, reflecting a +0.3% increase compared to the previous day.
• Concerns may have arisen initially due to an EVP selling over $500k in company stock; however, the overall positive market outlook and the company's solid fundamentals likely mitigated any apprehensions among investors.
• The company's consistent market outperformance over the last 15 years, with an average annual return of 14.9%, is a contributing factor to the high level of confidence and interest from investors.
• With an improved SmartSelect Composite Rating of 96, signaling that it is surpassing 96% of all stocks based on key criteria, Boston Scientific continues to receive favorable market sentiment.

01.06.2024 - BSX Stock was down 0.5%

• A conference call was announced by Boston Scientific to discuss its second-quarter 2024 results, which could have heightened investor anticipation and led to profit-taking.
• The positive news of securing a CE Mark for the DBS image-guided programming software might not have been sufficient to offset broader market trends or specific company performance concerns.
• The overall bearish movement in the market, particularly in the healthcare sector, could have influenced BSX's downward trajectory despite the positive developments within the company.
• The sector rotation away from tech and towards healthcare might have created uncertainty and volatility for BSX and contributed to the bearish market movement.

18.06.2024 - BSX Stock was down 1.2%

• Analysts predict that Boston Scientific Corporation (BSX) will announce an increase in revenue and adjusted earnings for the second quarter. Despite these positive forecasts, the stock displayed a bearish trend, suggesting potential disappointment or underperformance in the upcoming earnings release.
• The absence of the necessary factors for a likely earnings outperformance may have contributed to the prevailing bearish sentiment around BSX today.
• Comparisons with other medical sector stocks like Novavax (NVAX) and the relative strength ratings of companies such as Inari Medical (NARI) and ICU Medical (ICUI) could have diverted investor attention from Boston Scientific, resulting in a negative impact on its stock value.